Suppr超能文献

静脉输注利福平后人体血清和尿液中的浓度。

Serum and urine concentrations of rifampicin administered by intravenous infusion in man.

作者信息

Acocella G, Bonollo L, Mainardi M, Margaroli P, Tenconi L T

出版信息

Arzneimittelforschung. 1977;27(6):1221-6.

PMID:578447
Abstract

Two studies were carried out in man with the aim of assessing the serum and urine concentrations of rifampicin administered by i.v. infusion. In patients suffering from various diseases, a dose of 600 mg i.v. proved to be equieffective with a 600 mg oral dose. Repeated administration of a 600 mg dose by i.v. infusion for a week produced serum levels corresponding to those achieved by oral administration. With the i.v. preparation the drop in serum rifampicin levels during continuous administration was less marked than with the oral administration. The recovery of antibiotic in the urine seems to be lower with i.v. than with the oral preparation. The i.v. preparation was very well tolerated by all the patients.

摘要

进行了两项人体研究,目的是评估静脉输注利福平后的血清和尿液浓度。在患有各种疾病的患者中,静脉注射600毫克剂量被证明与口服600毫克剂量等效。通过静脉输注重复给予600毫克剂量一周,产生的血清水平与口服给药所达到的水平相当。使用静脉制剂时,持续给药期间血清利福平水平的下降比口服给药时不那么明显。静脉注射制剂在尿液中的抗生素回收率似乎低于口服制剂。所有患者对静脉制剂的耐受性都很好。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验